Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Aprepitant Capsules Market contains market size and forecasts of Aprepitant Capsules in global, including the following market information:
- Global Aprepitant Capsules Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Aprepitant Capsules Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Aprepitant Capsules companies in 2021 (%)
The global Aprepitant Capsules market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
80mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aprepitant Capsules include Merck, Sandoz, Glenmark Pharmaceuticals, Chia Tai Tianqing Pharmaceutical Group, Qilu Pharmaceutical and Camber Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Aprepitant Capsules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aprepitant Capsules Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aprepitant Capsules Market Segment Percentages, by Type, 2021 (%)
Global Aprepitant Capsules Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aprepitant Capsules Market Segment Percentages, by Application, 2021 (%)
Global Aprepitant Capsules Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aprepitant Capsules Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Aprepitant Capsules revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Aprepitant Capsules revenues share in global market, 2021 (%)
- Key companies Aprepitant Capsules sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Aprepitant Capsules sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Sandoz
- Glenmark Pharmaceuticals
- Chia Tai Tianqing Pharmaceutical Group
- Qilu Pharmaceutical
- Camber Pharma
Industry Market Size
